首页 | 本学科首页   官方微博 | 高级检索  
     

肺炎支原体的耐药状况及中医药研究进展
引用本文:姚凤莉,常凤媛,于雅彬. 肺炎支原体的耐药状况及中医药研究进展[J]. 国际儿科学杂志, 2011, 38(2): 191-194,封3. DOI: 10.3760/cma.j.issn.1673-4408.2011.02.030
作者姓名:姚凤莉  常凤媛  于雅彬
作者单位:北京军区总医院附属八一儿童医院儿童内科,100700
摘    要:肺炎支原体(mycoplasma pneumoniae,MP)是儿童呼吸道感染的常见病原体,大环内酯类抗生素是治疗小儿MP感染的首选药物.近年来MP对大环内酯类抗生素出现耐药,中医药治疗该病有较大优势.该文就MP的国内外耐药状况及中医药治疗小儿MP的优势、机制研究方面作一概述.

关 键 词:肺炎支原体  大环内酯类  耐药  中医药

Mycoplasma pneumoniae resistance and advances in traditional Chinese medicine
YAO Feng-li,CHANG Feng-yuan,YU Ya-bin. Mycoplasma pneumoniae resistance and advances in traditional Chinese medicine[J]. International Journal of Pediatrics, 2011, 38(2): 191-194,封3. DOI: 10.3760/cma.j.issn.1673-4408.2011.02.030
Authors:YAO Feng-li  CHANG Feng-yuan  YU Ya-bin
Abstract:Mycoplasma pneumoniae is a common pathogen of respiratory infection. Macrolides antibiotic is the first drug in treating children mycoplasma pneumoniae. Restently Mycoplasma pneumoniae shows resistance to macrolides antibiotic. Traditional Chinese medicine has more advantages in it. The paper summarizes drug resistance of mycoplasma pneumoniae and mechanisms research of traditional Chinese medicine.
Keywords:Mycoplasma pneumoniae  Macrolides antibiotic  Resistance  Traditional Chinese medicine
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号